A detailed history of Wellington Management Group LLP transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 9,411 shares of ANIP stock, worth $530,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,411
Previous 43,629 78.43%
Holding current value
$530,403
Previous $2.78 Million 79.81%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$54.33 - $65.72 $1.86 Million - $2.25 Million
-34,218 Reduced 78.43%
9,411 $561,000
Q2 2024

Aug 13, 2024

BUY
$58.53 - $68.82 $169,678 - $199,509
2,899 Added 7.12%
43,629 $2.78 Million
Q1 2024

May 15, 2024

BUY
$54.2 - $69.69 $2.21 Million - $2.84 Million
40,730 New
40,730 $2.82 Million
Q4 2023

Feb 12, 2024

BUY
$48.72 - $65.43 $454,167 - $609,938
9,322 New
9,322 $514,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.